Salt CompositionYou Searched
Rimactazid E 40 mg/300 mg/800 mg Tablet
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Tuberculosis (TB)
Customers also bought
More About Rimactazid E 40 mg/300 mg/800 mg Tablet
Benefits
In Treatment of Tuberculosis (TB) Tuberculosis is an infectious disease that mainly affects the lungs but can affect other parts of the body as well. Rimactazid E 40 mg/300 mg/800 mg Tablet helps treat tuberculosis by stopping the growth of bacteria causing infection. Your symptoms might improve after using Rimactazid E 40 mg/300 mg/800 mg Tablet. However, make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Rimactazid E 40 mg/300 mg/800 mg Tablet is to be taken empty stomach. Avoid Rimactazid E 40 mg/300 mg/800 mg Tablet with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
How it works
Rimactazid E 40 mg/300 mg/800 mg Tablet is a combination of three medicines: Rifampicin, isoniazid and ethambutol, which treats tuberculosis. Rifampicin works by inactivating a bacterial enzyme (RNA-polymerase) which is required by TB bacteria to make essential proteins and to reproduce, while isoniazid prevents these bacteria from forming their own protective covering. Together, they kill the bacteria and eradicate the infection. Ethambutol, on the other hand works by slowing the growth of these bacteria.
Unsafe: It is unsafe to consume alcohol while taking Rimactazid E 40 mg/300 mg/800 mg Tablet , as it may lead to symptoms such as flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure, known as a Disulfiram reaction.
Seek medical advice from your doctor: Rimactazid E 40 mg/300 mg/800 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Rimactazid E 40 mg/300 mg/800 mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Not Safe: Rimactazid E 40 mg/300 mg/800 mg Tablet may cause side effects which could affect your ability to drive. Rimactazid E 40 mg/300 mg/800 mg Tablet occasionally causes sight problems and tingling or numbness in hand or feet. After taking this medicine you should not drive until you know how it affects you.
Caution Advised: Rimactazid E 40 mg/300 mg/800 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Rimactazid E 40 mg/300 mg/800 mg Tablet may be needed. Doctor consultation is advised. Kidney function tests are advisable before the start of this medicine.
Caution Advised: Rimactazid E 40 mg/300 mg/800 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Rimactazid E 40 mg/300 mg/800 mg Tablet may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Rimactazid E 40 mg/300 mg/800 mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
References
Chemotherapy of Tuberculosis, Mycobacterium Avium Complex Disease, and Leprosy. In: Hilal-Dandan R, Brunton LL. Goodman and Gilman's Manual of Pharmacology and Therapeutics. 2nd ed. New York, New York: The McGraw-Hill Companies, Inc.; 2014 (10 Apr. 2019)
Isoniazid. Nottingham, Nottinghamshire: Boots Contract Manufacturing; 2015 (10 Apr. 2019)
Ethambutol. Ontario, Canada: Patheon Inc.; 2007 (10 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
